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ABSTRACT
The promoter of the human KRAS proto-oncogene
contains a structurally polymorphic nuclease hyper-
sensitive element (NHE) whose purine strand forms
a parallel G-quadruplex structure (called 32R). In a
previous work we reported that quadruplex 32R is
recognized by three nuclear proteins: PARP-1, Ku70
and hnRNP A1. In this study we describe the inter-
action of recombinant hnRNP A1 (A1) and its deriva-
tive Up1 with the KRAS G-quadruplex. Mobility-shift
experiments show that A1/Up1 binds specifically,
and also with a high affinity, to quadruplex 32R,
while CD demonstrates that the proteins strongly
reduce the intensity of the 260nm-ellipticity—the
hallmark for parallel G4-DNA—and unfold the
G-quadruplex. Fluorescence resonance energy
transfer melting experiments reveal that A1/Up1
completely abrogates the cooperative quadruplex-
to-ssDNA transition that characterizes the KRAS
quadruplex and facilitates the association between
quadruplex 32R and its complementary polypyrimi-
dine strand. When quadruplex 32R is stabilized by
TMPyP4, A1/Up1 brings about only a partial desta-
bilization of the G4-DNA structure. The possible role
played by hnRNP A1 in the mechanism of KRAS
transcription is discussed.
INTRODUCTION
The mammalian KRAS gene encodes for a guanine
nucleotide-binding protein of 21kDa that activates several
cellular pathways controlling important events such as
proliferation, diﬀerentiation and signalling (1). The Ras
proteins behave as a molecular switch cycling between
inactive GDP-bound and active GTP-bound states. The
state of nucleotide occupancy is regulated by speciﬁc pro-
teins named guanine nucleotides exchange factors (GEFs)
and GTPases activating proteins (GAPs) (1,2). The RAS
genes are frequently mutated in solid and haematological
neoplasias with single point mutations at exons 12, 13 and
61 (3,4). The most common mutated RAS gene in solid
tumours is KRAS, with a 90% incidence in pancreatic
adenocarcinomas (5,6). As the mutated Kras protein has
a defective GTPase activity, it is not inactivated by GAPs
(7). It remains locked into the GTP-bound active state
which continuously transmits to the nucleus mitotic sig-
nals that contribute to the neoplastic phenotypes in cancer
cells (8–10). As pancreatic adenocarcinomas are refractory
to conventional treatments, the discovery of new drugs
capable to sensitize tumour cells to chemotherapy is
being pursued in many laboratories. In our laboratory,
we focused on KRAS and in order to design anti-KRAS
drugs we investigated how the transcription of this proto-
oncogene is controlled. Previous studies have shown that
a nuclease hypersensitive element (NHE), located in the
KRAS promoter upstream of the transcription start
between –327 and –296, is responsible for most of the
transcription activity (11). Earlier we reported that the
purine strand of NHE is structurally polymorphic, as its
tract of sequence recognized by nuclear proteins is able to
fold into stable G-quadruplex structures (12,13). Using the
purine strand of NHE (called 32R) in quadruplex confor-
mation as a bait, we pulled down from a pancreatic
nuclear extract three proteins with aﬃnity for the KRAS
quadruplex. By SDS–PAGE and mass spectrometry, we
identiﬁed these proteins as poly[ADP-ribose] polymerase
1 (PARP-1), ATP-dependent DNA helicase 2, subunit 1
(Ku70) and heterogeneous ribonucleoprotein A1 (hnRNP
A1) (13). Protein hnRNP A1 (from now on A1) is a
member of the heterogeneous ribonucleoprotein family,
which is highly abundant in the nucleus of actively
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hnRNP family are characterized by two highly conserved
RNA recognition motifs (RRMs) at the N-terminus and
by a glycine-rich domain at the C-terminus (16,17).
Although a recent structure of a co-crystal of Up1 (a pro-
teolitic portion of A1 retaining binding activity) bound to
the telomeric repeat (TTAGGG)2 suggests that both
RRMs interact with DNA (18), it has been reported that
only one motif (RRM1) is suﬃcient for strong and speciﬁc
binding to single-stranded telomeric DNA (19) and that its
sub-element RNP11 mediates destabilization of quadru-
plex (CGG)n (20). Proteins hnRNP play various roles in
mRNA metabolism (14,15) and in the biogenesis of telo-
meres (21). As protein A1 (and its derivative Up1) was
reported to have a telomere-lengthening eﬀect in erytro-
leukemia cells (21,22), it is suspected to function as an
auxiliary factor of the telomerase holoenzyme (23).
Considering that the 30 G-rich repeats of the telomeres
are folded in stable G-quadruplex structures, it has been
hypothesized that A1 stimulates telomere elongation by
disrupting high-order structures formed by the telomere
repeats. Indeed, Up1 was reported to destabilize the bimo-
lecular quadruplex formed by human telomere repeats
d(TTAGGGTTAGGG), d(TTAGGG)4 and the intramo-
lecular quadruplex of d(GGCAG)5 (23–25).
Since we discovered that A1 is associated to the KRAS
promoter, in this study we have investigated the inter-
action between recombinant A1/Up1 and the KRAS
G-quadruplex. Electrophoretic mobility shift assay
(EMSA) showed that A1/Up1 binds to the KRAS quad-
ruplex with high aﬃnity and speciﬁcity, while CD and
ﬂuorescence resonance energy transfer (FRET) experi-
ments revealed that A1/Up1 destabilizes this non
B-DNA structure of the KRAS promoter. The results of
our study support a transcription mechanism in which A1
should function as a G-quadruplex destabilizing protein,
as it seems to occur in the G-rich 30 overhang strand of the
telomeres (23). In conclusion, this study sheds some light
on the mechanism of KRAS transcription regulation and
may be useful for the rationale design of anticancer drugs
speciﬁc for oncogenic KRAS.
MATERIALS AND METHODS
DNA and proteins hnRNP A1/Up1
The oligonucleotides used in this study (Table 1) were
obtained from MWG (Germany) and Microsynth
(Switzerland). They have been puriﬁed by 20% PAGE
(acrylamide: bisacrylamide, 19:1) in TBE, under denatur-
ing conditions (7M urea, 558C). The bands were excised
from the gel and eluted in water. The DNA solutions were
ﬁltered (Ultrafree-DA, Millipore) and precipitated. DNA
concentration was determined from the absorbance at
260nm of the oligonucleotides diluted in milli Q water,
using as extinction coeﬃcients 7500, 8500, 15000 and
12500M
 1cm
 1 for C, T, A and G, respectively. Dual-
labelled F-32R-T (50 end with FAM, 30 end with TAMRA)
were HPLC-puriﬁed.
Recombinant proteins Up1 and A1 tagged to GST were
expressed in Escherichia coli BL21 using plasmids
pGEX-Up1 and pGEX-hnRNP A1. After transformation,
the bacteria were grown for 2h at 378C with 50mg/ml
ampicillin to an A600 of 0.5–2.0 prior to induction with
IPTG (100mM ﬁnal concentration). Cells were allowed to
grow for 7h before harvesting. The cells were centrifuged
at 5000r.p.m., 48C. After centrifugation the supernatant
was removed carefully and the cells washed twice with
PBS. The pellet was re-suspended in a solution of PBS
with PMSF 100mM and DTT 1M. The bacteria were
lysed by sonication, added with Triton X-100 (1% ﬁnal
concentration) and incubated for 30min on a shaker at
room temperature. The lysate was then centrifuged for
10min at 48C at 10000r.p.m. Glutathione Sepharose 4B
(GE Healthcare) (50% slurry in PBS) was added to the
supernatant and incubated for 30min at 48C on a shaker.
The mix was centrifuged for 5min at 500g and the
pellet was washed 5 times in PBS and eluted with elution
buﬀer containing 20mM NaCl, 20mM reduced glu-
tathione, 200mM Tris–HCl, pH 9.5 for A1 elution and
pH 7.5 for Up1 elution. Alternatively, to remove the
GST tag, the mix was centrifuged for 5min at 500g,
washed with PreScission Cleavage buﬀer (GE Healthcare)
and centrifuged 5min at 500g. The pellet was incubated
for 4h at 48C with PreScission protease to cleave the GST
tag from the puriﬁed proteins. After PreScission cleavage,
the A1 or Up1 moieties were detached from GST
which remained bound to the Gluthatione Sephadex
beads. The reaction mixtures were centrifuged for 5min
at 500g,4 8C, and the untagged proteins collected
from the supernatant. Finally, the puriﬁcation of tagged
and untagged Up1 and A1 proteins were checked by
SDS–PAGE.
CD and fluorescence experiments
CD spectra have been obtained with a JASCO J-600 spec-
tropolarimeter equipped with a thermostatted cell holder.
CD experiments were carried out with oligonucleotides
(3mM) in 50mM Tris–HCl, pH 7.4, 100mM KCl.
Spectra were recorded in 0.5cm quartz cuvette. A ther-
mometer inserted in the cuvette holder allowed a precise
measurement of the sample temperature. The spectra were
calculated with J-700 Standard Analysis software (Japan
Spectroscopic Co., Ltd) and are reported as ellipticity
(mdeg) versus wavelength (nm). Each spectrum was
recorded three times, smoothed and subtracted to the
baseline.
Fluorescence measurements were carried out with a
Microplate Spectroﬂuorometer System (Molecular
Devices) using a 96-well black plate, in which each well
contained 50ml of 200nM dual-labelled F-32R-T in
50mM Tris–HCl, pH 7.4 and KCl as speciﬁed in
the ﬁgure captions. Before adding the protein, the samples
were incubated for 24h at room temperature in the speci-
ﬁed buﬀer. The protein (Up1, A1 or BSA) was added
30min before ﬂuorescence analysis. The emission spectra
were obtained by setting the excitation wavelength at
475nm, the cut-oﬀ at 515nm and recording the emission
from 500 to 650nm. Upon addition of KCl, F-32R-T
assumes a folded quadruplex conformation and FRET is
expected between the 50 and 30 ﬂuorophores. The emission
2842 Nucleic Acids Research, 2009, Vol. 37,No. 9intensity of the donor (FAM) decreases while the intensity
of the acceptor increases, correspondingly, as K
+ is added
to the sample solution. The energy transfer from the
donor to the acceptor and vice versa can be empirically
represented by the parameter P:
P ¼
ID
ðID þ IAÞ
where ID and IA are the intensities of the donor and accep-
tor (26,27). Fluorescence melting experiments were per-
formed on a real-time PCR machine (iQ5, BioRad),
using a 96-well plate ﬁlled with 50ml solutions of dual-
labelled F-32R-T. The protocol used for the melting
experiments is the following: (i) equilibration step of
5min at low temperature (158C); (ii) stepwise increase of
the temperature of 18C per min for 76 cycles to reach
958C. All samples in the wells were melted in 76min.
Kinetic experiments were carried out using the iQ5 real-
time machine. Oligonucleotide F-32R-T (200nM) in
100mM KCl, i.e. in the quadruplex conformation, was
mixed with the complementary 32Y strand and the
increase at 525nm of the ﬂuorescence was measured as a
function of time. The experiment was also performed
adding to F-32R-T a mixture containing 32Y (8-fold)
and Up1 (400nM). The increase of ﬂuorescence
F=F F0, where F0 and F is the ﬂuorescence at
525nm (FAM) at t=0 and at any time t, was best-ﬁtted
to a single or double-exponential curve. The half-life of the
reaction is given by t1/2=0.693/k.
EMSA
Oligonucleotides 32R, HRAS-1, HRAS-2, CMYC, CKIT,
VEGF, 32Y, Gmut1 and Gmut2 were end-labelled with
[g-
33P]ATP and T4 polynucleotide kinase. Duplex
dsNHE was prepared annealing (10min at 958C, over-
night at room temperature) a mixture containing equimo-
lar amounts of radiolabelled 32R and complementary
32Y in 50mM Tris–HCl, pH 7.4, 100mM NaCl. Before
EMSA, the quadruplex-forming oligonucleotides were
allowed to form their structure in 50mM Tris–HCl,
pH 7.4, 100mM KCl, 378C (overnight incubation).
Radiolabelled oligonucleotides (35nM) were treated for
30min at room temperature with diﬀerent amounts
of A1/Up1, (r ([protein]/[oligonucleotide]) ratios are
speciﬁed in Figure 3) in 20mM Tris–HCl, pH 8, 30mM
KCl, 1.5mM MgCl2, 1mM DTT, 8% glycerol, 1%
Phosphatase Inhibitor Coktail I (Sigma, Milan, Italy),
5mM NaF, 1mM Na3VO4, 2.5ng/ml poly [dI-dC]. After
incubation, the reaction mixtures were loaded in 8% TBE
(1 ) polyacrylamide gel, thermostatted at 168C. After
running the gel was dried and exposed to autoradiography
(G E Healthcare, Milan) for 24–36h at –808C.
Polymerase-stop assay
A linear DNA fragment of 87nt, containing the G-rich
element of NHE, was used as a template for Taq polymer-
ase primer-extension reactions. This DNA sequence was
puriﬁed by PAGE. The template (100nM) was mixed with
the labelled primer (50nM) in 100mM KCl, Taq buﬀer
1  and overnight incubated at 508C. The primer extension
reactions were carried out for 1h, by adding 10mM DTT,
100mM dATP, dGTP, dTTP, dCTP and 3.75U of Taq
polymerase (Euro Taq, Euroclone, Milan). The reactions
were stopped by adding an equal volume of stop buﬀer
(95% formamide, 10mM EDTA, 10mM NaOH, 0.1%
xylene cyanol, 0.1% bromophenol blue). The products
were separated on a 15% polyacrylamide sequencing gel
prepared in TBE, 8M urea. The gel was dried and exposed
to autoradiography. Standard dideoxy sequencing reac-
tions were performed to detect the points in which DNA
polymerase I was arrested.
RESULTS
We previously demonstrated that the G-rich strand of
NHE can form G-quadruplex structures (13,28). By
means of CD and DMS-footprinting experiments we
found that the G-tract called 32R forms a parallel
G-quadruplex characterized by three G-tetrads (Tm of
708C in 100mM KCl) (Figure 1). Pull-down assays with
a pancreatic nuclear extract combined to mass spectrome-
try showed that quadruplex 32R binds to three proteins:
PARP-1 (116kDa), Ku70 (72kDa) and A1 (34kDa) (13).
Since A1 is involved in the biogenesis of the telomeres as a
G4-DNA destabilizing protein (23) and is able to disrupt
the secondary structures of the hypervariable minisatellite
sequence d(GGCAG)5 (24), we asked whether A1/Up1
can have a similar functional role in the human KRAS
promoter. To address this question, recombinant A1 and
its derivative Up1 were expressed in Escherichia coli as
proteins fused to GST and puriﬁed by aﬃnity chromatog-
raphy with glutathione sepharose 4B. The GST moiety
was removed with a pre-scission protease and recombi-
nant tagged and untagged proteins were obtained with a
high purity level (Figure 2). Up1 is a proteolitic fragment
(195 aa) of A1 (319 aa) that retains the two RNA-recogni-
tion motifs (RRMs) responsible for binding to nucleic
acids (18,22).
The interaction between A1/Up1 and a variety of DNA
substrates, some of which were structured in G4-DNA
and some not, was analysed by EMSA.
33P-labelled 32R
(35nM) was ﬁrst incubated for 24h in 100mM KCl to
allow quadruplex formation, then incubated for 30min
with increasing amounts of Up1 or A1: r ([protein]/
[32R])=0, 0.5, 1, 2, 5, 10, 20, 50, 100. As preliminary
experiments showed that GST-tagged and untagged pro-
teins behave in the same way, we performed EMSA with
the tagged proteins. Figure 3a and b shows that quadru-
plex 32R forms with A1/Up1 a DNA–protein complex
that, being detected even at r=0.5, should have a 1:1
stoichiometry. In addition, for r>20, another slow-
migrating DNA–protein complex appears in the gel,
most likely due to a 1:2 complex. When r was increased
to 200 and the samples run in a longer gel, 32R migrated
essentially as 1:2 complex (Figure 3c). The formation of
two DNA–protein complexes by A1/Up1 is in keeping
with the results of Zhang et al. (23) and the crystal struc-
ture of d(TTAGGG)2 bound to Up1 (18). Since a tract of
12nt functions as a minimum binding unit, 32R has
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Figure 2. Schematic representations of proteins hnRNP A1 and Up1. The two RNA-recognition motifs (RRMs), that mediate ssDNA binding,
contain each two conserved RNP2 and RNP1 submotifs. Up1 encompasses the amino-terminal two-third of the hnRNPA1 sequence. SDS–PAGE of
GST-tagged and untagged hnRNP A1 and Up1, after gluthatione sepharose 4B puriﬁcation. Lane 1, protein markers; lane 2, total extract (hnRNP
A1); lane 3, supernatant; lane 4, puriﬁed GST-tagged hnRNP A1; lane 5, puriﬁed untagged hnRNP A1; lane 6, total extract (Up1); lane 7,
supernatant; lane 8, puriﬁed GST-tagged Up1; lane 9, puriﬁed untagged Up1.
CCTCCCCCTCTTCCCTCTTCCCACACCGCCC
5’GCTCGCTG       TCAGCCGCTCCCT 3’
3’CGAGCGACGGAGGGGGAGAAGGGAGAAGGGTGTC GGAGTCGGCGAGGGA 5’
S SE x   φ Ex 1 Ex 2 Ex 3 Ex 4A Ex 4B
5’ 3’
+1
H
32R
3’
5’
3’
3
5’
GG G
Figure 1. Sequence of the nuclease hypersensitive element (NHE) in the human KRAS promoter. The G-rich sequence 32R forms a G-quadruplex
whose putative structure, consistent with CD and dimethyl sulfate footprinting, is G4-DNA1, which is characterized either by a ﬂipped-out thymidine
connecting G7 to G9 or a GGGT triad (13). The expected G4-DNA2 structure is not supported by dimethyl sulfate footprinting. The nucleotides of
32R (Table 1) are numbered from the 50-end.
2844 Nucleic Acids Research, 2009, Vol. 37,No. 9potentially two binding sites, which can in principle form
two DNA–protein complexes by binding one or two
protein molecules. By quantifying the intensity of the
electrophoretic bands, we roughly estimated that the
dissociation constant Kd of the 1:1 complex is about
50nM for Up1 and 200nM for A1. We also tested the
binding speciﬁcity of A1/Up1 for a variety of well
known G-quadruplex structures obtained from CMYC,
CKIT, VEGF and HRAS promoter sequences (29–32)
(for HRAS quadruplexes, see Supplementary Data S1)
(Figure 3d and e). The various DNA substrates have
been
33P-labelled and treated with an excess of protein
(r=50). It can be seen that A1 shows good speciﬁcity
for the KRAS quadruplex, as it does not bind to the
other quadruplex-forming sequences, unstructured oligo-
nucleotides Gmut1, Gmut2, 32Y (the complementary
polypyrimidinic NHE strand) and dsNHE (32R:32Y)
(Table 1). Instead, protein Up1, besides quadruplex 32R,
shows aﬃnity also for the CKIT quadruplex and unstruc-
tured oligonucleotides.
To analyse the eﬀect of A1/Up1 on the KRAS
G-quadruplex, we could not employ electrophoresis
because the mobility between an intramolecular quadru-
plex and its unfolded form is not very diﬀerent. Therefore,
we used spectroscopic techniques such as circular dichro-
ism (CD) and FRET. Figure 4 shows that in 100mM KCl,
32R is characterized by a CD signature typical of a par-
allel G-quadruplex: a strong and positive ellipticity at
260nm and a weak and negative ellipticity at 240nm
(33). When quadruplex 32R is denatured by increasing
the temperature, the positive 260nm band is dramatically
reduced and its spectrum becomes similar to that of
unstructured oligonucleotides (data not shown). Thus,
the structural transition from quadruplex-to-ssDNA is
accompanied by a strong reduction of the 260nm ellipti-
city. A similar transition was obtained by adding to
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Figure 3. (a, b) EMSA of 35nM
33P-labelled quadruplex 32R after 30min incubation with increasing amounts of Up1 or A1at the speciﬁed r values,
in 20mM Tris–HCl, pH 8, 30mM KCl, 1.5mM MgCl2, 1mM DTT, 8% glycerol, 1% Phosphatase Inhibitor Coktail I (Sigma), 5nM NaF, 1mM
Na3VO4, 2.5ng/ml poly dI-dC, for 258C. The analyses were carried out in 8% polyacrylamide gel (29:1) in TBE (1 )a t1 6 8C. Before the EMSA, 32R
was incubated overnight in 100mM KCl to get it in the G-quadruplex conformation; (c) EMSA as in (a, b) but with r values up to 200; (d, e) EMSA
of A1/Up1 mixed to various DNA substrates [G-quadruplexes 32R, HRAS-1, HRAS-2, CMYC, CKIT, VEGF, dsNHE (32R:32Y) and unstructured
oligonucleotides Gmut1, Gmut2, 32Y]. PAGE carried out in 8% polyacrylamide gel (29:1) in TBE (1 )a t1 6 8C.
Nucleic Acids Research,2009, Vol.37, No. 9 2845quadruplex 32R increasing amounts of A1/Up1 (r=1,2,
4, 6). It can be seen that the protein causes a progressive
reduction of the 260nm ellipticity, indicating that the
G4-DNA structure is unfolded by the protein. As a con-
trol, we treated quadruplex 32R with an unrelated protein,
the trypsinogen inhibitor, and found that the 260nm ellip-
ticity was not aﬀected and remained constant at all protein
concentrations used. The CD spectra of Up1 at increasing
concentrations show that the protein between 240 and
320nm does not have any negative band, but below
240nm it shows a negative band typical of the polypeptide
backbone. The CD data showing G-quadruplex unfolding
are in keeping with those previously obtained with the
telomeric TTAGGG repeat (24,25) and the hypervariable
minisatellite sequence d(GGCAG)5 treated with Up1 (24).
The unfolding of the human KRAS quadruplex by
A1/Up1 was also investigated by FRET, using the quad-
ruplex-forming sequences tagged at the 50 and 30 ends with
FAM (donor) and TAMRA (acceptor) (34). By exciting
F-32R-T at 475nm, the emission intensity of the donor
at 525nm decreases while the emission intensity of the
acceptor at 580nm increases, as the KCl concentration
is increased from 0 to 140mM (Supplementary Data
S2). F-32R-T folded in the G-quadruplex conformation
(Tm=758C in 140mM KCl) is characterized by a
P-value of 0.52 (see ‘Materials and methods’ section).
This P-value is higher than that observed for the quadru-
plex formed by the human telomeric repeat d(GGGTTAG
GGTTAGGGTTAGGG) (26), because F-32R-T forms
a parallel quadruplex where the two ﬂuorophores
are at opposite ends of the structure (13). When the
G-quadruplex is destabilized by scaling down the KCl
concentration to zero or by adding the complementary
32Y strand, that transforms the G-quadruplex into a
B-DNA duplex where the donor and acceptor are sepa-
rated by about 115A ˚ , the donor ﬂuorescence signiﬁcantly
increases (for instance, from spectrum 2 to spectrum 1,
Figure 5a) and the P-value becomes 0.75. This means
that the unfolding of quadruplex F-32R-T is accompanied
Table 1. Oligonucleotides (50 > 30) used in this study
AGGGCGGTGTGGGAAGAGGGAAGAGGGGGAGG 32R
F-AGGGCGGTGTGGGAAGAGGGAAGAGGGGGAGG-T F-32R-T
AGGGAGGGCGCTGGGAGGAGGG CKIT
GGGCGGGCCGGGGGCGGGTCCCGGCGGGG VEGF
TGGGGAGGGTGGGGAGGGTGGGGAAGG CMYC
TCGGGTTGCGGGCGCAGGGCACGGGCG HRAS-1
CGGGGCGGGGCGGGGGCGGGGGCG HRAS-2
GCGGTGTGTGAAGAGTGAAGAGTGGGATGCAG Gmut1
GCATTCTGATTACACGTATTACCTTCACTCCA Gmut2
CCTCCCCCTCTTCCCTCTTCCCACACCGCCCT 32Y
GTACTACACTTGATA primer
ACCTTGATGAATCCAGGGCGGTGTGGGAAGAG
GGAAGAGGGGGAGGAATCGCTACCGTTAAGCA
TCGATCATATCAAGTGATAGTAC
template
F: FAM; T: TAMRA.
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2846 Nucleic Acids Research, 2009, Vol. 37,No. 9by a P=0.75 0.52=0.23. We then asked if quadru-
plex F-32R-T is unfolded by A1/Up1. To choose at which
ionic strength the FRET experiments in the presence of
A1/Up1 should be performed, we measured the Tm of
quadruplex F-32R-T in KCl and NaCl solutions (in 50,
100 and 140mM KCl, Tm is 48, 70 and 758C, respectively;
in 100mM NaCl, the Tm is 328C). Figure 5a shows the
eﬀect on quadruplex F-32R-T in 50mM KCl (Tm=488C,
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Figure 5. (a) Fluorescence spectra of 200nM F-32R-T in water (spectrum 1) or 50mM Tris–HCl, pH 7.4, 50mM KCl in the absence (spectrum 2) or
presence of BSA (r=10, spectrum 3) or Up1 (r=0.5, 1, 3, 6, 10, spectra 4–8); (b) row FRET-melting curves (F525 versus T) obtained with the iQ5
real-time PCR machine of quadruplex F-32R-T treated with A1/Up1at various [protein]/[DNA] ratios, in 50mM Tris pH 7.4, 50mM KCl. As
reference a melting curve of F-32R-T in the presence of BSA (r=10) is reported. Bottom panels show the corresponding ﬁrst derivative curves,
–dF525/dT versus T. The G-quadruplex was incubated with the protein for 30min prior to melting; (c) schematic representation of the U-shape
structure of the DNA–protein complex between F-32R-T and Up1.
Nucleic Acids Research,2009, Vol.37, No. 9 2847P=0.62) of Up1 and A1 at r=1, 2, 3, 6, 10. It can be
seen that, compared to complementary 32Y, Up1 does not
promote a signiﬁcant increase of the donor emission, a
behaviour that might suggest that Up1 has little eﬀect
on the quadruplex conformation [for instance the
P-value is 0.62 at r=0 (spectrum 2), 0.67 at r=10 (spec-
trum 8), P=0.05]. If we assume that P=0.23 reﬂects
total opening of the G-quadruplex, P=0.05 suggests
that F-32R-T bound to Up1 is partially opened (20%).
Alternatively, it is possible that F-32R-T in the DNA–
protein complex is completely opened but with the 50
and 30 ends brought close to one another so that FRET
takes place. To gain insight into this possibility we per-
formed melting experiments. We reasoned that in case the
quadruplex is partially unfolded, its Tm would be lowered,
whereas in case it is completely opened by A1/Up1, the
quadruplex-to-ssDNA transition should be abrogated.
Figure 5b shows typical melting curves for quadruplex
F-32R-T in 50mM KCl, obtained with a real-time PCR
machine, after the DNA was incubated for 30min with
A1/Up1 (r=1, 2, 4, 10) or BSA (r=10) just before melt-
ing. It can be seen that an excess of BSA does not change
the Tm of the G-quadruplex, as one expects with an unspe-
ciﬁc protein which does not interact with DNA. In con-
trast, when quadruplex F-32R-T is incubated with A1/
Up1, a strong change of the melting curves is observed.
The cooperative transition relative to the denaturation of
the G-quadruplex (Tm of 488C) is completely abrogated
and replaced with a broad and non-cooperative curve,
which reﬂects the disruption of the DNA–protein com-
plex. The abrogation of the quadruplex-to-ssDNA transi-
tion is clearly observed with both F versus T and –dF/dT
versus T curves. A similar behaviour has been reported for
the UV-melting of the virus type 1 nucleocapsid protein
bound to the quadruplex formed by d(GGGTTGGTGTG
GTTGG) (35). In 100mM NaCl, where quadruplex F-
32R-T shows a cooperative transition with a Tm of
328C, we also observed the abrogation of the cooperative
transition by A1/Up1 (Figure 6). These data suggest that
when F-32R-T is bound to A1/Up1, its secondary struc-
ture is completely disrupted and F-32R-T in the DNA–
protein complex is in the single-stranded form. The fact
that the opening of the quadruplex by Up1 is accompa-
nied by a P which is 20% of that observed with 32Y
(0.05 against 0.23) can be rationalized on the basis of the
crystal structure between Up1 and the telomeric repeat (T
TAGGG)2 (18). In the crystal, the two RRM elements
within a Up1 molecule bind to two separate 12mer oligo-
nucleotides, which are antiparallel and separated by an
interstrand distance of 25–50A ˚ . Thus, we expect that F-
32R-T bound to A1/Up1 adopts a U-shape with the two
ﬂuorophores close enough to promote energy transfer (18)
(Figures 5c).
It is well known that the cationic porphyrin TMPyP4
stabilizes quadruplex DNA by stacking externally to the
G-tetrads and interacting with the loop nucleotides (36).
We therefore tested whether TMPyP4 reduces the
quadruplex destabilizing action of A1/Up1. Quadruplex
F-32R-T (200nM) was incubated for 12h in 50mM
KCl, in the presence of 200 and 600nM TMPyP4.
Figure 7a shows that TMPyP4 enhances the Tm of quad-
ruplex F-32R-T from 488C (curve 1) to 68 (curve 4) and
768C (curve 5). The mixtures were treated for 30min with
1mMA 1( r=5) and then melted. While A1 at r=5 is able
to completely disrupt the KRAS quadruplex in 50mM
KCl (see Figure 5b), in the presence of the porphyrin it
promotes only a partial destabilization of the G-quadru-
plex: the Tm is reduced from 688Ct o5 8 8C (in the presence
of 200nM TMPyP4, curve 2, Figure 7a) or from 768Ct o
638C (600nM TMPyP4, curve 3, Figure 7a). So, the sta-
bilizing eﬀect of the porphyrin partially inhibits the capac-
ity of the protein to unfold the G-quadruplex. To exclude
the possibility that TMPyP4 directly interacts with and
inhibits A1, we performed a control experiment with
TMPyP2, the positional isomer of TMPyP4 showing lit-
tle aﬃnity for quadruplex DNA (Figure 7b). As expected,
TMPyP2 neither stabilizes appreciably quadruplex 32R,
nor impairs the unfolding of the quadruplex structure
by A1. These experiments provide a possible molecular
mechanism that explains how TMPyP4 is found to repress
the activity of the KRAS promoter (12,13).
Krainer and co-workers (23) showed that A1/Up1 binds
to the single-stranded and structured human telo-
meric repeat (TTAGGG)n=2, 4. They suggest that A1
is likely to function as an auxiliary factor of the telo-
merase holoenzyme and propose that the protein
stimulates telomerase elongation through unwinding of
the G-quadruplex structures formed during the
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2848 Nucleic Acids Research, 2009, Vol. 37,No. 9translocation steps. Our study suggests that protein A1,
being a component of a multiprotein complex formed
within NHE (13), may have a similar function for the
KRAS promoter: i.e. to resolve the folded quadruplex
conformations. The destabilizing activity of A1 should
facilitate a quadruplex-to-duplex transformation, that
seems to be necessary to activate transcription (12,13).
To test this hypothesis, we investigated whether the kinetic
of hybridization between quadruplex F-32R-T and the
complementary 32Y strand becomes faster in the presence
of Up1. When quadruplex F-32R-T in 100mM KCl
(Tm=708C) is mixed at 258C with the 32Y strand the
quadruplex sequence is transformed into the more stable
duplex (Tm=788C) and the ﬂuorescence of the donor
increase as in the duplex it is separated from the acceptor
(Figure 8a, from A to C). This assembly process can be
monitored by measuring the increase of donor (FAM)
ﬂuorescence, F, as a function of time (F=F F0,
where F0 is the FAM ﬂuorescence at 525nm at t=0
and F the ﬂuorescence at time t). The F versus t curve
shows an exponential shape that was best-ﬁtted to a
double-exponential equation (37). For the slow phase a
constant kslow of 1.56 10
–3 6 10
–5s
–1 was obtained
(Figure 8b). The hybridization performed in the presence
of Up1 occurs with a faster kinetic which was nicely best-
ﬁtted to a single-exponential equation: k=5.2 10
–3s
–1.
In this case the assembly occurs between F-32R-T bound
to Up1 and 32Y, the ﬂuorescence increases from B to C
(Figure 8b). The half-life t1/2 for the hybridization of 32R
to 32Y in the presence of Up1 is 133s, while in the absence
of Up1 is 444s, i.e. more than 3 times higher. This demon-
strates that Up1 is indeed a G4-DNA destabilizing protein
that facilitates the quadruplex-to-duplex transformation
within NHE.
Finally, by a primer extension assay using a template
containing the KRAS G-rich element we tested whether
A1/Up1 is able to remove the block to Taq polymerase
caused by quadruplex formation (12,13,24). Figure 9
shows that when the template is incubated in 100mM
KCl prior to primer extension, Taq polymerase is arrested
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Nucleic Acids Research,2009, Vol.37, No. 9 2849at the 30 end of the G-rich tract, as this element folds into a
G-quadruplex structure. Contrarily to what we expected,
the addition of increasing amounts of protein A1/Up1
strengthened the pause of Taq polymerase. The precise
points at which Taq polymerase was arrested were deter-
mined by Sanger sequencing reactions and are indicated
with arrows in the template sequence. This suggests that
A1/Up1 forms with the DNA template a complex which
is suﬃciently stable to arrest the processivity of Taq
polymerase. That’s why A1/Up1 enhances the block of
Taq polymerase at the G-rich element. However, to cor-
roborate this hypothesis DNA footprinting experiments
should be done to demonstrate direct binding of A1/
Up1 to the site of arrest. The complex between A1/Up1
and 32R is destabilized when the G-rich strand hybridizes
to its complementary sequence to aﬀord a B-DNA duplex
for which A1/Up1 has no aﬃnity (see EMSA). Finally, in
keeping with the results in Figure 3, the primer-extension
assay shows that A1/Up1 binds to the G-rich tract of
NHE with a high selectivity, since signiﬁcant arrests of
polymerase at other points of the template are not
observed.
DISCUSSION
This work describes the ability of A1, and its derivative
Up1, to destabilize the quadruplexes of the KRAS pro-
moter and to facilitate their hybridization to the comple-
mentary polypyrimidine strand. In accord with pull-down
experiments (13), EMSA conﬁrmed that recombinant
Up1 and A1 bind to the KRAS quadruplex with a high
aﬃnity and sequence-speciﬁcity, as the binding to other
G-quadruplex structures such as HRAS1, HRAS2,
CMYC, VEGF appeared either weak or inconsistent.
Only the quadruplex from the CKIT sequence (Table 1)
is recognised by Up1. The association of A1 to the KRAS
promoter is restricted to the polypurine strand, as EMSA
shows that A1 does not bind to the complementary poly-
pyrimidine strand, nor to NHE in duplex conformation.
Considering that the minimum length for strong binding
to Up1 is a stretch of 12 nucleotides (18), 32R, being com-
posed by 32 nucleotides, has potentially two binding sites.
In fact, EMSA shows that 32R forms two DNA–protein
complexes that are expected to have a stoichiometry of
1:1 and 1:2 (DNA:Up1). This is in accord with the results
of Zhang et al. (23) showing that Up1 forms with the
telomeric repeats (TTAGGG)4 two DNA–protein
complexes.
In accord with previous observations (24,25), A1 and
Up1 promote a signiﬁcant reduction of the 260nm ellip-
ticity, typical of G4-DNA in the parallel conformation.
This demonstrates that both proteins are able to unfold
the quadruplex structures of the KRAS promoter. This
conclusion is further supported by FRET-melting experi-
ments showing that the quadruplex formed by F-32R-T is
completely disrupted by A1 or Up1. When the KRAS
G-quadruplex is incubated for 30min with A1/Up1
before melting, the cooperative transition of the G-quad-
ruplex is replaced by a non-cooperative transition. This
suggests that when the KRAS sequence is bound to
A1/Up1, it is open and in a single-stranded conformation,
as shown by the crystal of Up1 with the telomeric repeat
(18). In contrast, when a 10-fold excess BSA is added to
the G-quadruplex, no change in the quadruplex transition
is observed. We interestingly found that protein A1/Up1
facilitates the assembly into a duplex of the two comple-
mentary NHE strands. In fact, the half-life of renaturation
is reduced from 444 to 133s in the presence of Up1,
100mM KCl. This is in accord with earlier studies report-
ing that A1 promotes a rapid renaturation of nucleic-acid
strands, probably by melting the secondary structures that
are formed transiently during the annealing process (38).
The ﬁnding that A1 resolves the KRAS quadruplexes has
an important biological signiﬁcance because previous stu-
dies supported the notion that the KRAS G4-DNA might
behave as a transcription suppressor (12,13,28)
The role of A1 in vivo has been investigated in the con-
text of the telomere biogenesis (21–23). One possible func-
tion of the protein would be to disrupt the G4-DNA
structures of the telomere G-repeats, allowing proper
elongation by the telomerase (23). The data of our study
suggest that A1 could have a similar function in the tran-
scription of KRAS. This is in keeping with the fact that
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Figure 8. (a) FRET spectra of 200 nM F-32R-T in 50mM KCl, in the
presence of BSA (r=10), Up1 (r=10) and 6-fold complementary 32Y
strand. (b) Increase of ﬂuorescence F as a function of time following
the addition to 200 nM F-32R-T of 6-fold complementary 32Y in
50mM Tris pH 7.4, 100mM KCl. Exc 475nm; Em 525nm. The exper-
iment has been conducted in the absence and presence of Up1 (r=3).
The solid lines are the best-ﬁts of the experimental points with an
exponential equation (SigmaPlot 11, Systat Software Inc).
2850 Nucleic Acids Research, 2009, Vol. 37,No. 9NHE but not to the complementary pyrimidinic strand or
duplex NHE; (ii) disrupts G4-DNA and (iii) facilitates the
assembly of the NHE strands into a duplex. A possible
model for transcription regulation of KRAS is the follow-
ing. NHE should exist in equilibrium between a folded
(quadruplex) and a double-stranded conformation. In
the folded form the promoter is locked into a form that
might inhibit transcription (12,13). To activate transcrip-
tion, the folded form of NHE should hybridize to the
complementary strand in order to restore the duplex.
As the quadruplex-to-duplex transformation is likely to
be kinetically slow, the functions of A1 would be of desta-
bilizing the quadruplex and allow the G-rich strand to
hybridize to its complementary within a time compatible
with a response of the cell to molecular stimuli. There are
a number of genes with C+G-rich elements in the region
surrounding the transcription start site that seems to be
characterized by a transcription regulation mechanism
involving G-quadruplex structures (12,13,39–45).
Several proteins from diﬀerent organisms that interact
with quadruplex DNA have been reported (46). They can
be classiﬁed by function into ﬁve major groups: (i) pro-
teins that increase the stability of DNA quadruplexes;
(ii) proteins that destabilize quadruplex DNA in a non
catalytic way; (iii) proteins that unwind catalytically
quadruplex DNA in an ATP-dependent fashion; (iv) pro-
teins that promote the formation of quadruplex DNA;
(v) Nucleases that speciﬁcally cleave DNA at or adjacently
to a quadruplex domain. Like other members of the
hnRNP family such as hnRNP A2 (20) and CBF-A
(20,47) that destabilise the G-quadruplex formed by the
d(CGG)n fragile X expanded sequence, protein A1 acts on
DNA in a non-catalytic way, i.e. remaining bound to the
DNA substrate. Another protein with a similar property
is POT-1 which binds to the telomere G-rich DNA over-
hangs and disrupts G4-DNA structures (48,49). However,
contrarily to A1/Up1, POT-1 causes a signiﬁcant increase
of the P-value of the quadruplex from the human telo-
meric repeat, because in the DNA-protein complex the
telomeric repeat assumes an extended conformation in
which the donor–acceptor are separated by a distance
that is too long for FRET (26). Similarly, A1 disrupts
the G4-DNA structures assumed by NHE and its remain-
ing bound to the G-rich sequence prevents the DNA from
assuming again the folded conformation. We were indeed
surprised to observe by primer extension experiments that
G4-DNA
full-length 
product
primer
A1 - - ---+    +    +
Up1 - +   +  +  +   - - -
r 0     1    2    5  10  1   5   10
5´- ..ACCTTGATGAATCCAGGGCGGTGTGGGAAGAGGGAAGAGGGGGAGGAATCGCTACCGTTA..-3´
DNA-protein
complex
G-rich tract (32R)
template
Figure 9. Primer extension assay showing that Taq polymerase pauses at the G-rich element of KRAS where the template forms G-quadruplex
structures in the presence of KCl. The 87-mer DNA template (100nM) was mixed with
33P-labelled primer (50nM) (Table 1) and incubated for 24h
in 140mM KCl to allow quadruplex formation by the G-rich element. The mixtures were added with increasing amounts of Up1 (lanes 2–5) or A1
(lanes 6–8), r=[protein]/[DNA] as speciﬁed, and incubated for 30min prior to primer extension. Taq polymerase is arrested at the G-rich element
due to quadruplex formation. In the presence of Up1 or A1 the polymerase arrest is stronger. The points in which Taq polymerase is arrested, have
been identiﬁed by standard Sanger sequencing reactions. Primer extension reaction performed at 378C for 1h. Reaction products separated in a 12%
Urea-TBE denaturing gel.
Nucleic Acids Research,2009, Vol.37, No. 9 2851at 378C, A1/Up1 did not remove the block to Taq poly-
merase and the protein even enhanced the polymerase
arrest. This clearly indicates that after interaction the pro-
tein remains bound to the template, and the resulting
DNA–protein complex is suﬃciently strong to arrest the
processivity of the polymerase.
Finally, the proposed transcription regulation model
suggests two strategies to downregulate the KRAS onco-
gene and sensitize pancreatic cancer cells, which are
refractory to conventional treatment, to chemotherapy.
First, use of G4-ligands that lock the promoter in the
non-transcriptable form by stabilizing the G-quadru-
plexes; second, use of decoy molecules speciﬁc for the
proteins that recognize the G4-DNA structure of NHE
(28). Work is in progress in our laboratory along this
direction.
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